Ceva

塞瓦

animal health

动物健康

, the world's fifth largest animal health company announces the acquisition of

，全球第五大动物保健公司宣布收购

Aquilón CyL S.L., a Spanish biotechnology company specialised in research, diagnostics, and the development of innovative biological solutions for swine diseases.

Aquilón CyL S.L. 是一家西班牙生物技术公司，专注于研究、诊断以及开发针对猪病的创新生物解决方案。

Founded in 2012 and based in León – Spain, Aquilón is a spin-off from the university of León. The company has a proven track record of more than a decade in applied studies of the pig digestive tract and in the development of biological tools that translate academic knowledge into commercial solutions with real on-farm impact..

Aquilón成立于2012年，总部位于西班牙莱昂，是莱昂大学衍生出的一家初创企业。该公司在猪消化道应用研究以及开发生物工具方面拥有十余年的良好业绩记录，能够将学术知识转化为具有实际农场应用效果的商业解决方案。

A strategic addition to Ceva’s swine disease prevention offer

对 Ceva 猪病预防产品线的战略性补充

This acquisition enhances Ceva’s swine intestinal health portfolio. It includes the first and only European commercial vaccine targeting Brachyspira hyodysenteriae, the bacterium responsible for swine dysentery, a major enteric disease causing severe economic losses globally.

此次收购增强了Ceva公司的猪肠道健康产品组合。其中包括首款且唯一一款针对猪痢疾密螺旋体（Brachyspira hyodysenteriae）的欧洲商业化疫苗，该细菌是引起猪痢疾的病原体，而猪痢疾是一种在全球范围内造成严重经济损失的主要肠道疾病。

“I am delighted by this opportunity to further strengthen Ceva’s swine intestinal health portfolio. Aquilón brings a solution that helps prevent an important disease and reduce antibiotic dependence said Dr. Marc Prikazsky, Executive Chaiman of Ceva Animal Health.

“我很高兴有机会进一步加强Ceva的猪肠道健康产品组合。Aquilón带来了一种有助于预防重要疾病并减少对抗生素依赖的解决方案。” Ceva动物保健公司执行董事长Marc Prikazsky博士表示。

Smooth integration and strengthened scientific capabilities

无缝整合与强化的科研能力

Upon completion of the transaction, Aquilón’s team of scientists will join Ceva, reinforcing its global research and

交易完成后，Aquilón的科学家团队将加入Ceva，加强其全球研究和

innovation capabilities in swine health. Their expertise will accelerate the development and roll-out of new vaccines and diagnostic tools supporting reduced antibiotic use and more sustainable production.

在猪健康领域的创新能力。他们的专业知识将加速新疫苗和诊断工具的开发与推广，从而支持减少抗生素使用并实现更可持续的生产。

Carlos Artigas, Director of Aquilón, commented on the acquisition: “We are proud to see our team and our flagship innovation find the ideal environment for growth within Ceva. With its global reach and strong technical capabilities, Ceva will provide outstanding support for the further development and commercialisation of this solution.”.

Aquilón 总监卡洛斯·阿蒂加斯就此次收购发表评论：“我们很高兴看到我们的团队和旗舰创新产品在 Ceva 内部找到了理想的成长环境。凭借其全球影响力和强大的技术实力，Ceva 将为该解决方案的进一步开发和商业化提供卓越的支持。”

Terms of the transaction were not disclosed.

交易条款未予披露。

https://www.bionity.com/en/news/1188892/ceva-animal-health-acquires-biotech-spin-off-from-the-university-of-leon.html

https://www.bionity.com/en/news/1188892/ceva-animal-health-acquires-biotech-spin-off-from-the-university-of-leon.html

Ceva Animal Health invests in new 7,000 m² vaccine manufacturing facility to expand global production capacity

Ceva动物保健公司投资新建7,000平方米疫苗生产设施，以扩大全球生产能力

Read news

阅读新闻

Most read news

阅读最多的新闻

1

1

Miltenyi Biotec expands Cologne production site for clinical reagents

Miltenyi Biotec 扩大科隆生产基地以生产临床试剂

2

2

Egg consumption is associated with a lower risk of Alzheimer’s Disease

鸡蛋摄入量与较低的阿尔茨海默病风险相关

3

3

Cytospire Therapeutics announces oversubscribed £61 million Series A financing

Cytospire Therapeutics 宣布超额认购的 6100 万英镑 A 轮融资

4

4

The ‘Ozempic Era’ could shift blame for obesity from individuals to the food industry

“奥兹匹克时代”或将把肥胖的责任从个人转向食品行业

5

5

Coffee doesn’t just wake you up — it may help protect your body from aging

咖啡不仅能提神醒脑，还可能有助于保护身体免受衰老影响

Topics

主题

animal health

动物健康

takeovers

收购

vaccines

疫苗

bowel diseases

肠道疾病

Show all

显示全部

Show less

显示更少

Organizations

组织

Ceva Santé Animale

塞瓦动物保健